FEops HEARTguideTM vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FEops HEARTguideTM

by FEops

AVIEW

by Coreline Soft Co.

AI Verdict

FEops HEARTguideTM is designed for pre-procedural planning of structural heart interventions, offering predictive simulations for device sizing and positioning. In contrast, AVIEW provides a broader diagnostic platform for lung conditions and coronary artery calcification scoring from CT scans. While both leverage AI for cardiovascular imaging analysis, their primary clinical applications and specific functionalities cater to distinct needs within cardiology and radiology.

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if your primary need is highly precise, patient-specific pre-procedural planning for complex structural heart interventions like TAVI or LAAO. This tool is ideal for clinicians seeking predictive simulations and digital twin technology to optimize device sizing and positioning, thereby enhancing procedural safety and efficacy.

View FEops HEARTguideTM →

Choose AVIEW if…

Choose AVIEW if your focus is on comprehensive, AI-driven screening and long-term monitoring for a range of thoracic and cardiovascular conditions, including lung cancer, COPD, and coronary artery calcification. This platform is best suited for radiology departments and pulmonology clinics aiming to streamline workflows and improve diagnostic precision across multiple pathologies from CT scans.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FEops HEARTguideTM	AVIEW
Pricing	Unknown	Subscription; one-off payment
Deployment	Cloud-based	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AVIEW

AVIEW offers superior usability through its comprehensive workflow automation and integration with PACS/RIS/CIS, which are critical for seamless adoption in radiology departments. Its flexible deployment options also cater to diverse IT environments, enhancing accessibility. While FEops provides interactive viewing, AVIEW's broader integration and automation streamline existing clinical processes more effectively.

Clinical Value

FEops HEARTguideTM

FEops HEARTguide provides predictive simulations and anatomical insights specifically for optimizing complex structural heart interventions like TAVI and LAAO. This direct impact on pre-procedural planning aims to improve procedural efficiency and patient outcomes, representing a high level of clinical value by directly guiding critical interventions.

Pricing & Value

AVIEW

AVIEW offers greater transparency in its pricing model, providing options for subscription or one-off payments based on installations and users. This clarity allows healthcare organizations to better understand costs and assess value. In contrast, FEops HEARTguide's pricing is not publicly disclosed and operates on a service-based model, making it harder to evaluate its overall value proposition.

Enterprise Readiness

AVIEW

AVIEW demonstrates stronger enterprise readiness with its highly flexible deployment options, including cloud, hybrid, local on dedicated hardware, and locally virtualized solutions. This adaptability accommodates various institutional IT infrastructures and security policies. Additionally, its explicit integration with PACS/RIS/CIS ensures smoother incorporation into existing clinical workflows.

Innovation

FEops HEARTguideTM

FEops HEARTguide stands out for its innovative use of AI and 'digital twin' technology to provide predictive simulations for optimizing structural heart device sizing and positioning. This capability goes beyond diagnostic assistance to actively model and guide complex interventional procedures, representing a more advanced and potentially disruptive application of AI in healthcare.

Support & Docs

FEops HEARTguideTM

FEops HEARTguide explicitly mentions a dedicated support email ([email protected]) and provides 'training slide decks on the platform' for user education. The existence of formal software documentation for FDA clearance also indicates a structured approach to information. While AVIEW offers technical brochures, FEops' direct support channels and in-platform training suggest more accessible and user-focused support resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FEops HEARTguideTM	AVIEW
Name	FEops HEARTguideTM	AVIEW
Company	FEops nv	Coreline Soft Co.
Primary Focus / Application	Structural heart procedure planning (TAVI, LAAO) with predictive simulations and anatomical insights.	Early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.
Specialties Supported	Cardiology, Cardiothoracic Surgery, Radiology	Cardiology, Pulmonology, Radiology
Categories	Cardiology AI	Cardiology AI, Oncology AI, Radiology & Imaging AI
Key Feature Example	Predictive simulation technology for device-anatomy interaction	AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score)

Videos

Demos, reviews, and walkthroughs featuring FEops HEARTguideTM and AVIEW.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of FEops HEARTguideTM compared to AVIEW?

FEops HEARTguideTM is designed for structural heart procedure planning, offering predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. AVIEW, on the other hand, provides comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.

What specific AI-driven analyses do these platforms offer for cardiovascular assessment?

FEops HEARTguideTM provides predictive simulation technology for device-anatomy interaction and AI-based anatomical measurements from CT scans to optimize device sizing and positioning for TAVI and LAAO. AVIEW offers coronary artery calcium (CAC) scoring, including Agatston, volume, and mass scores for risk stratification, along with automated segmentation of coronary arteries.

How do these tools integrate into existing clinical workflows?

FEops HEARTguideTM features a DICOM interface for easy integration into clinical workflows. AVIEW provides workflow automation and integration capabilities with PACS/RIS/CIS.

Which medical specialties are primarily targeted by each tool?

FEops HEARTguideTM primarily targets Cardiology, Cardiothoracic Surgery, and Radiology for structural heart procedure planning. AVIEW is designed for Cardiology, Pulmonology, and Radiology, focusing on lung and coronary artery conditions.